Glycosylated Biosimilars Market - Global Outlook and Forecast 2021-2027

Code: RW00014629803
Market Monitor Global
Nov-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Glycosylated Biosimilars in Global, including the following market information:
Global Glycosylated Biosimilars Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Glycosylated Biosimilars market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Glycosylated Biosimilars companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glycosylated Biosimilars Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Glycosylated Biosimilars Market Segment Percentages, By Type, 2020 (%)
mAb
EPO

China Glycosylated Biosimilars Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Glycosylated Biosimilars Market Segment Percentages, By Application, 2020 (%)
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases

Global Glycosylated Biosimilars Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Glycosylated Biosimilars Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Glycosylated Biosimilars Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Glycosylated Biosimilars Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Glycosylated Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glycosylated Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glycosylated Biosimilars Overall Market Size
2.1 Global Glycosylated Biosimilars Market Size: 2021 VS 2027
2.2 Global Glycosylated Biosimilars Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Glycosylated Biosimilars Players in Global Market
3.2 Top Global Glycosylated Biosimilars Companies Ranked by Revenue
3.3 Global Glycosylated Biosimilars Revenue by Companies
3.4 Top 3 and Top 5 Glycosylated Biosimilars Companies in Global Market, by Revenue in 2020
3.5 Global Companies Glycosylated Biosimilars Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glycosylated Biosimilars Players in Global Market
3.6.1 List of Global Tier 1 Glycosylated Biosimilars Companies
3.6.2 List of Global Tier 2 and Tier 3 Glycosylated Biosimilars Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Glycosylated Biosimilars Market Size Markets, 2021 & 2027
4.1.2 mAb
4.1.3 EPO
4.2 By Type - Global Glycosylated Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Glycosylated Biosimilars Revenue, 2016-2021
4.2.2 By Type - Global Glycosylated Biosimilars Revenue, 2022-2027
4.2.3 By Type - Global Glycosylated Biosimilars Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Glycosylated Biosimilars Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Chronic Diseases
5.1.4 Autoimmune Diseases
5.1.5 Blood Disorders
5.1.6 Growth Hormone Deficiency
5.1.7 Infectious Diseases
5.1.8 Other Diseases
5.2 By Application - Global Glycosylated Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Glycosylated Biosimilars Revenue, 2016-2021
5.2.2 By Application - Global Glycosylated Biosimilars Revenue, 2022-2027
5.2.3 By Application - Global Glycosylated Biosimilars Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Glycosylated Biosimilars Market Size, 2021 & 2027
6.2 By Region - Global Glycosylated Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Glycosylated Biosimilars Revenue, 2016-2021
6.2.2 By Region - Global Glycosylated Biosimilars Revenue, 2022-2027
6.2.3 By Region - Global Glycosylated Biosimilars Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Glycosylated Biosimilars Revenue, 2016-2027
6.3.2 US Glycosylated Biosimilars Market Size, 2016-2027
6.3.3 Canada Glycosylated Biosimilars Market Size, 2016-2027
6.3.4 Mexico Glycosylated Biosimilars Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Glycosylated Biosimilars Revenue, 2016-2027
6.4.2 Germany Glycosylated Biosimilars Market Size, 2016-2027
6.4.3 France Glycosylated Biosimilars Market Size, 2016-2027
6.4.4 U.K. Glycosylated Biosimilars Market Size, 2016-2027
6.4.5 Italy Glycosylated Biosimilars Market Size, 2016-2027
6.4.6 Russia Glycosylated Biosimilars Market Size, 2016-2027
6.4.7 Nordic Countries Glycosylated Biosimilars Market Size, 2016-2027
6.4.8 Benelux Glycosylated Biosimilars Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Glycosylated Biosimilars Revenue, 2016-2027
6.5.2 China Glycosylated Biosimilars Market Size, 2016-2027
6.5.3 Japan Glycosylated Biosimilars Market Size, 2016-2027
6.5.4 South Korea Glycosylated Biosimilars Market Size, 2016-2027
6.5.5 Southeast Asia Glycosylated Biosimilars Market Size, 2016-2027
6.5.6 India Glycosylated Biosimilars Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Glycosylated Biosimilars Revenue, 2016-2027
6.6.2 Brazil Glycosylated Biosimilars Market Size, 2016-2027
6.6.3 Argentina Glycosylated Biosimilars Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Glycosylated Biosimilars Revenue, 2016-2027
6.7.2 Turkey Glycosylated Biosimilars Market Size, 2016-2027
6.7.3 Israel Glycosylated Biosimilars Market Size, 2016-2027
6.7.4 Saudi Arabia Glycosylated Biosimilars Market Size, 2016-2027
6.7.5 UAE Glycosylated Biosimilars Market Size, 2016-2027
7 Players Profiles
7.1 Sandoz
7.1.1 Sandoz Corporate Summary
7.1.2 Sandoz Business Overview
7.1.3 Sandoz Glycosylated Biosimilars Major Product Offerings
7.1.4 Sandoz Glycosylated Biosimilars Revenue in Global (2016-2021)
7.1.5 Sandoz Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Glycosylated Biosimilars Major Product Offerings
7.2.4 Pfizer Glycosylated Biosimilars Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Teva Pahrmaceutical
7.3.1 Teva Pahrmaceutical Corporate Summary
7.3.2 Teva Pahrmaceutical Business Overview
7.3.3 Teva Pahrmaceutical Glycosylated Biosimilars Major Product Offerings
7.3.4 Teva Pahrmaceutical Glycosylated Biosimilars Revenue in Global (2016-2021)
7.3.5 Teva Pahrmaceutical Key News
7.4 Celltrion
7.4.1 Celltrion Corporate Summary
7.4.2 Celltrion Business Overview
7.4.3 Celltrion Glycosylated Biosimilars Major Product Offerings
7.4.4 Celltrion Glycosylated Biosimilars Revenue in Global (2016-2021)
7.4.5 Celltrion Key News
7.5 Biocon
7.5.1 Biocon Corporate Summary
7.5.2 Biocon Business Overview
7.5.3 Biocon Glycosylated Biosimilars Major Product Offerings
7.5.4 Biocon Glycosylated Biosimilars Revenue in Global (2016-2021)
7.5.5 Biocon Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Glycosylated Biosimilars Major Product Offerings
7.6.4 Amgen Glycosylated Biosimilars Revenue in Global (2016-2021)
7.6.5 Amgen Key News
7.7 Samsung Biologics
7.7.1 Samsung Biologics Corporate Summary
7.7.2 Samsung Biologics Business Overview
7.7.3 Samsung Biologics Glycosylated Biosimilars Major Product Offerings
7.4.4 Samsung Biologics Glycosylated Biosimilars Revenue in Global (2016-2021)
7.7.5 Samsung Biologics Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Glycosylated Biosimilars Major Product Offerings
7.8.4 Mylan Glycosylated Biosimilars Revenue in Global (2016-2021)
7.8.5 Mylan Key News
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Corporate Summary
7.9.2 Dr. Reddy's Laboratories Business Overview
7.9.3 Dr. Reddy's Laboratories Glycosylated Biosimilars Major Product Offerings
7.9.4 Dr. Reddy's Laboratories Glycosylated Biosimilars Revenue in Global (2016-2021)
7.9.5 Dr. Reddy's Laboratories Key News
7.10 Stada Arzneimittel AG
7.10.1 Stada Arzneimittel AG Corporate Summary
7.10.2 Stada Arzneimittel AG Business Overview
7.10.3 Stada Arzneimittel AG Glycosylated Biosimilars Major Product Offerings
7.10.4 Stada Arzneimittel AG Glycosylated Biosimilars Revenue in Global (2016-2021)
7.10.5 Stada Arzneimittel AG Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Glycosylated Biosimilars Market Opportunities & Trends in Global Market
Table 2. Glycosylated Biosimilars Market Drivers in Global Market
Table 3. Glycosylated Biosimilars Market Restraints in Global Market
Table 4. Key Players of Glycosylated Biosimilars in Global Market
Table 5. Top Glycosylated Biosimilars Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Glycosylated Biosimilars Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Glycosylated Biosimilars Revenue Share by Companies, 2016-2021
Table 8. Global Companies Glycosylated Biosimilars Product Type
Table 9. List of Global Tier 1 Glycosylated Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glycosylated Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Glycosylated Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Glycosylated Biosimilars Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Glycosylated Biosimilars Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Glycosylated Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Glycosylated Biosimilars Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Glycosylated Biosimilars Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Glycosylated Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Glycosylated Biosimilars Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Glycosylated Biosimilars Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Glycosylated Biosimilars Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Glycosylated Biosimilars Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Glycosylated Biosimilars Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Glycosylated Biosimilars Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Glycosylated Biosimilars Revenue, (US$, Mn), 2022-2027
Table 30. Sandoz Corporate Summary
Table 31. Sandoz Glycosylated Biosimilars Product Offerings
Table 32. Sandoz Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Glycosylated Biosimilars Product Offerings
Table 35. Pfizer Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 36. Teva Pahrmaceutical Corporate Summary
Table 37. Teva Pahrmaceutical Glycosylated Biosimilars Product Offerings
Table 38. Teva Pahrmaceutical Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 39. Celltrion Corporate Summary
Table 40. Celltrion Glycosylated Biosimilars Product Offerings
Table 41. Celltrion Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 42. Biocon Corporate Summary
Table 43. Biocon Glycosylated Biosimilars Product Offerings
Table 44. Biocon Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 45. Amgen Corporate Summary
Table 46. Amgen Glycosylated Biosimilars Product Offerings
Table 47. Amgen Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 48. Samsung Biologics Corporate Summary
Table 49. Samsung Biologics Glycosylated Biosimilars Product Offerings
Table 50. Samsung Biologics Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 51. Mylan Corporate Summary
Table 52. Mylan Glycosylated Biosimilars Product Offerings
Table 53. Mylan Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 54. Dr. Reddy's Laboratories Corporate Summary
Table 55. Dr. Reddy's Laboratories Glycosylated Biosimilars Product Offerings
Table 56. Dr. Reddy's Laboratories Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
Table 57. Stada Arzneimittel AG Corporate Summary
Table 58. Stada Arzneimittel AG Glycosylated Biosimilars Product Offerings
Table 59. Stada Arzneimittel AG Glycosylated Biosimilars Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Glycosylated Biosimilars Segment by Type
Figure 2. Glycosylated Biosimilars Segment by Application
Figure 3. Global Glycosylated Biosimilars Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Glycosylated Biosimilars Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Glycosylated Biosimilars Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glycosylated Biosimilars Revenue in 2020
Figure 8. By Type - Global Glycosylated Biosimilars Revenue Market Share, 2016-2027
Figure 9. By Application - Global Glycosylated Biosimilars Revenue Market Share, 2016-2027
Figure 10. By Region - Global Glycosylated Biosimilars Revenue Market Share, 2016-2027
Figure 11. By Country - North America Glycosylated Biosimilars Revenue Market Share, 2016-2027
Figure 12. US Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Glycosylated Biosimilars Revenue Market Share, 2016-2027
Figure 16. Germany Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 17. France Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Glycosylated Biosimilars Revenue Market Share, 2016-2027
Figure 24. China Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 28. India Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Glycosylated Biosimilars Revenue Market Share, 2016-2027
Figure 30. Brazil Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Glycosylated Biosimilars Revenue Market Share, 2016-2027
Figure 33. Turkey Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Glycosylated Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 37. Sandoz Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Teva Pahrmaceutical Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Celltrion Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Biocon Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Amgen Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Samsung Biologics Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Mylan Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Dr. Reddy's Laboratories Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Stada Arzneimittel AG Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE